Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Allergan Ltd
Marlow International, The Parkway, Marlow, Bucks, SL7 1YL, UK
Telephone: +44 (0)1628 494444
Fax: +44 (0)1628 494449
WWW: http://www.allergan.co.uk
Medical Information Direct Line: +44 (0)1628 494026
Medical Information e-mail: UK_MedInfo@Allergan.com
Out of Hours contact: +44 (0)1628 494026

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 29/11/2011
PIL BOTOX 50 Units

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 29/11/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to dosage and administration
  • Changes to therapeutic indications
Updated on 11/10/2011 and displayed until 29/11/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
Updated on 12/08/2010 and displayed until 11/10/2011
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to side-effects
Updated on 16/07/2010 and displayed until 12/08/2010
Reasons for adding or updating:
  • Change to side-effects
  • PIL Submitted in error
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to dosage and administration
  • Changes to therapeutic indications
Updated on 29/08/2008 and displayed until 16/07/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
  • Change to information about driving or using machinery
  • Change to date of revision
Updated on 15/08/2008 and displayed until 29/08/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 01/04/2008 and displayed until 15/08/2008
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
  botulinum toxin type a